Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
jnj.comTotal trials
465
Active
0
Phase 3
193
Total enrollment
818,634
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Schizophrenia73
- Healthy55
- Anemia54
- Epilepsy19
- Seizures17
- Bipolar Disorder17
- Diabetes Mellitus, Type 217
- Obesity16
Frequently asked questions about Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- How many clinical trials does Johnson & Johnson Pharmaceutical Research & Development, L.L.C. have on ClinicalTrials.gov?
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. is listed as the lead sponsor on 465 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Johnson & Johnson Pharmaceutical Research & Development, L.L.C.'s trials are in Phase 3?
- 193 of Johnson & Johnson Pharmaceutical Research & Development, L.L.C.'s trials are in Phase 3.
- What therapeutic areas does Johnson & Johnson Pharmaceutical Research & Development, L.L.C. focus on?
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.'s most-studied conditions on ClinicalTrials.gov are Schizophrenia, Healthy, Anemia, Epilepsy, Seizures.